InsiderSignal.AI

InsiderSignal.ai

ALMS - Alumis Inc.

Insider Purchase by Foresite Capital Management VI LLC (10%)

3 Months
After Trade
Before Trade

Loading data...

Trade Summary

1 month ago, Foresite Capital Management VI LLC, serving as 10% owner at Alumis Inc. (ALMS), purchased 411,764 shares at $17.00 per share, for a total transaction value of $6,999,988.00. Following this transaction, Foresite Capital Management VI LLC now holds 10,487,268 shares of ALMS.

This purchase represents a 4.00% increase in Foresite Capital Management VI LLC's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, January 8, 2026 and publicly disclosed via SEC Form 4 filing on Monday, January 12, 2026, 4 days after the trade was made.

Alumis Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Foresite Capital Management VI LLC

Foresite Capital Management VI LLC

10%

Foresite Capital Management VI LLC is a Delaware-incorporated investment entity (CIK: 0002013341, EIN: 881484823) affiliated with Foresite Capital, a multi-stage healthcare and life sciences investment firm headquartered at 900 Larkspur Landing Circle, Suite 150, Larkspur, CA 94939.[[1]](https://www.sec.gov/Archives/edgar/data/2013341/000110465925076821/0001104659-25-076821-index.html)[[2]](https://www.foresitecapital.com)[[4]](https://www.nasdaq.com/market-activity/institutional-portfolio/foresite-capital-management-vi-llc-1300795) It serves as the management entity for Foresite Capital Fund VI, L.P., employing a data science-driven approach to invest in companies at the intersection of technology, biology, and big data to address unmet needs in healthcare.[[2]](https://www.foresitecapital.com)[[5]](https://whalewisdom.com/filing/foresite-capital-fund-vi-lp-sc-13g-2024-02-23-engn) As a 10% Owner of Alumis Inc. (ALMS), Foresite Capital Management VI LLC holds approximately 15,705,828 shares valued over $281 million, reflecting its active role in institutional investing and recent trading activities.[[3]](https://www.gurufocus.com/insider/264443/foresite-capital-management-vi-llc) The firm files quarterly 13F-HR reports with the SEC, disclosing holdings in biotech and life sciences firms such as CG Oncology, Inc. and RAPT Therapeutics, Inc., underscoring its focus on transformative healthcare opportunities.[[1]](https://www.sec.gov/Archives/edgar/data/2013341/000110465925076821/0001104659-25-076821-index.html)[[6]](https://fintel.io/i/foresite-capital-management-vi-llc-6860)

View full insider profile →

Trade Price

$17.00

Quantity

411,764

Total Value

$6,999,988.00

Shares Owned

10,487,268

Trade Date

Thursday, January 8, 2026

45 days ago

SEC Filing Date

Monday, January 12, 2026

Filed 4 days after trade

HEALTHCAREBIOTECHNOLOGY

About Alumis Inc.

Company Overview

No company information available
View news mentioning ALMS

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/3054400

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime